Protective Effect of Recombinant Interferon (IFN)-.ALPHA./.BETA. on MHV-2cc-induced Chronic Hepatitis in Athymic Nude Mice.
- 1 January 1996
- journal article
- Published by Japanese Association for Laboratory Animal Science in Experimental Animals
- Vol. 45 (3) , 293-297
- https://doi.org/10.1538/expanim.45.293
Abstract
The protective effects of recombinant IFN-α/ β on MHV-2cc-induced chronic and persistent hepatitis in athymic nude mice were examined. The mice intraperitoneally (ip) inoculated with MHV-2cc at day 0 of experiment were divided into 4 groups. Three of them were administered ip with recombinant IFN-α/β at a daily dose of 1 × 103 IU from -1 (-1D-group), 0 (0D-group), and +1 day of experiment (+1D-group), respectively, for 3 consecutive weeks. The remaining one (control group) was given 0.1 ml/mouse of PBS from +1 day of the experiment in the same way. Three mice in each group were killed at 1, 2 and 3 weeks post inoculation (WPI) with MHV, respectively. The liver virus titer in the control group increased gradually and maintained high levels throughout the experimental period. In the IFN-groups, particularly in the -1D- and 0D-groups, the virus titers were significantly lower than that in control group. Histopathologically, focal hepatic lesions were observed at 1WPI and large irregular inflammatory lesions developed at 3WPI in the control group. Similar but somewhat less severe lesions were observed in the +1D-group. In the -1D- and 0D-groups, lesions were not observed at 1WPI and only small organized lesions with mononuclear cell infiltration were seen at 3WPI. In conclusion, it was clarified in the present study that the progression of MHV-2cc-induced chronic hepatitis in athymic nude mice was effectively prevented by extrinsic IFN-α/β when administered from -1 day and 0 day of the virus infection.Keywords
This publication has 15 references indexed in Scilit:
- High doses of recombinant $alpha;-interferon or $gamma;-interferon for chronic hepatitis C: A randomized, controlled trial*1Hepatology, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.BMJ, 1989
- Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.BMJ, 1989
- Protective effect of recombinant murine interferon beta against mouse hepatitis virus infectionAntiviral Research, 1987
- Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus type 2Digestive Diseases and Sciences, 1986
- Establishment of persistently infected DBT cell cultures with mouse hepatitis virus strains, MHV-2 and MHV-3.The Japanese Journal of Veterinary Science, 1984
- Herpes Simplex Virus Type 1-induced Interferon Production and Activation of Natural Killer Cells in MiceJournal of General Virology, 1983
- Mode of regulation of natural killer cell activity by interferonThe Journal of Experimental Medicine, 1980